Re­verse merg­ers say hey as biotechs trade low, hunt for al­ter­na­tives and launch few IPOs

The re­verse merg­er an­nounced Wednes­day morn­ing be­tween Ma­gen­ta Ther­a­peu­tics and pri­vate­ly-held Di­anthus Ther­a­peu­tics, which will take over the Nas­daq spot and push for­ward its com­ple­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.